Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mounting evidence suggests Sputnik COVID vaccine is safe and effective.

Literature DB >> 34230663

Mounting evidence suggests Sputnik COVID vaccine is safe and effective.

Bianca Nogrady.

Abstract

Entities: Disease

Keywords: Epidemiology; SARS-CoV-2; Vaccines

Year: 2021 PMID： 34230663 DOI： 10.1038/d41586-021-01813-2

Source DB: PubMed Journal: Nature ISSN： 0028-0836 Impact factor: 49.962

× No keyword cloud information.

2 in total

1. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.

Authors: Denis Y Logunov; Inna V Dolzhikova; Dmitry V Shcheblyakov; Amir I Tukhvatulin; Olga V Zubkova; Alina S Dzharullaeva; Anna V Kovyrshina; Nadezhda L Lubenets; Daria M Grousova; Alina S Erokhova; Andrei G Botikov; Fatima M Izhaeva; Olga Popova; Tatiana A Ozharovskaya; Ilias B Esmagambetov; Irina A Favorskaya; Denis I Zrelkin; Daria V Voronina; Dmitry N Shcherbinin; Alexander S Semikhin; Yana V Simakova; Elizaveta A Tokarskaya; Daria A Egorova; Maksim M Shmarov; Natalia A Nikitenko; Vladimir A Gushchin; Elena A Smolyarchuk; Sergey K Zyryanov; Sergei V Borisevich; Boris S Naroditsky; Alexander L Gintsburg
Journal: Lancet Date: 2021-02-02 Impact factor: 79.321

2. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.

Authors: Denis Y Logunov; Inna V Dolzhikova; Olga V Zubkova; Amir I Tukhvatullin; Dmitry V Shcheblyakov; Alina S Dzharullaeva; Daria M Grousova; Alina S Erokhova; Anna V Kovyrshina; Andrei G Botikov; Fatima M Izhaeva; Olga Popova; Tatiana A Ozharovskaya; Ilias B Esmagambetov; Irina A Favorskaya; Denis I Zrelkin; Daria V Voronina; Dmitry N Shcherbinin; Alexander S Semikhin; Yana V Simakova; Elizaveta A Tokarskaya; Nadezhda L Lubenets; Daria A Egorova; Maksim M Shmarov; Natalia A Nikitenko; Lola F Morozova; Elena A Smolyarchuk; Evgeny V Kryukov; Vladimir F Babira; Sergei V Borisevich; Boris S Naroditsky; Alexander L Gintsburg
Journal: Lancet Date: 2020-09-04 Impact factor: 202.731

2 in total

20 in total

Review 1. Controversy surrounding the Sputnik V vaccine.

Authors: Mario Cazzola; Paola Rogliani; Filomena Mazzeo; Maria Gabriella Matera
Journal: Respir Med Date: 2021-08-10 Impact factor: 4.582

Review 2. Adverse Events and Safety of SARS-CoV-2 Vaccines: What's New and What's Next.

Authors: Kristen B Corey; Grace Koo; Elizabeth J Phillips
Journal: J Allergy Clin Immunol Pract Date: 2022-05-10

3. Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina.

Authors: Rossana Elena Chahla; Rodrigo Hernán Tomas-Grau; Silvia Inés Cazorla; Diego Ploper; Esteban Vera Pingitore; Mónica Aguilar López; Patricia Aznar; María Elena Alcorta; Eva María Del Mar Vélez; Agustín Stagnetto; César Luís Ávila; Carolina Maldonado-Galdeano; Sergio Benjamín Socias; Dar Heinze; Silvia Adriana Navarro; Conrado Juan Llapur; Dardo Costa; Isolina Flores; Alexis Edelstein; Shreyas Kowdle; Claudia Perandones; Benhur Lee; Gabriela Apfelbaum; Raúl Mostoslavsky; Gustavo Mostoslavsky; Gabriela Perdigón; Rosana Nieves Chehín
Journal: Lancet Reg Health Am Date: 2021-11-20

10. Onset of Oral Lichenoid Lesions and Oral Lichen Planus Following COVID-19 Vaccination: A Retrospective Analysis of about 300,000 Vaccinated Patients.

Authors: Moritz Hertel; Andrea-Maria Schmidt-Westhausen; Stephanie Wendy; Max Heiland; Susanne Nahles; Robert Preissner; Saskia Preissner
Journal: Vaccines (Basel) Date: 2022-03-20

Mounting evidence suggests Sputnik COVID vaccine is safe and effective.

1. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.

2. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.

Review 1. Controversy surrounding the Sputnik V vaccine.

Review 2. Adverse Events and Safety of SARS-CoV-2 Vaccines: What's New and What's Next.

3. Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina.

Review 4. SARS-CoV-2 Vaccination in India: Considerations of Hesitancy and Bioethics in Global Health.

5. Antibody responses induced by Sputnik V vaccine in individuals previously infected with SARS-CoV-2.

6. COVID-19 Vaccines Cost-Effectiveness Analysis: A Scenario for Iran.

Review 7. The Rise of Vectored Vaccines: A Legacy of the COVID-19 Global Crisis.

8. A case series of vaccine-induced thrombotic thrombocytopenia in a London teaching hospital.

Review 9. Utilization of Viral Vector Vaccines in Preparing for Future Pandemics.

10. Onset of Oral Lichenoid Lesions and Oral Lichen Planus Following COVID-19 Vaccination: A Retrospective Analysis of about 300,000 Vaccinated Patients.